BioHarvest Sciences Total Current Assets 2020-2024 | BHST
BioHarvest Sciences total current assets from 2020 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
BioHarvest Sciences Annual Total Current Assets (Millions of US $) |
2023 |
$9 |
2022 |
$4 |
2021 |
$6 |
2020 |
$2 |
2019 |
$1 |
2019 |
$1 |
2018 |
$1 |
BioHarvest Sciences Quarterly Total Current Assets (Millions of US $) |
2024-06-30 |
$9 |
2024-03-31 |
$8 |
2023-12-31 |
$9 |
2023-09-30 |
$5 |
2023-06-30 |
$5 |
2023-03-31 |
$3 |
2022-12-31 |
$4 |
2022-09-30 |
$5 |
2022-06-30 |
$3 |
2022-03-31 |
$3 |
2021-12-31 |
$6 |
2021-09-30 |
$8 |
2021-06-30 |
$5 |
2021-03-31 |
$7 |
2020-12-31 |
$2 |
2020-09-30 |
$3 |
2020-06-30 |
$3 |
2020-03-31 |
|
2019-12-31 |
|
2019-09-30 |
|
2019-06-30 |
|
2019-03-31 |
$1 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|